Yang Zhiwei, Huang Xin, Jiang Hong, Zhang Yanrong, Liu Hongxia, Qin Chuan, Eisner Gilbert M, Jose Pedro A, Rudolph Lenhard, Ju Zhenyu
Institute of Laboratory Animal Sciences and Max-Planck-Partner Group on Stem Cell Aging, Chinese Academy of Medical Sciences, Panjiayuan Nanli 5, Chaoyang District, Beijing 100021, China.
Hypertension. 2009 Apr;53(4):639-45. doi: 10.1161/HYPERTENSIONAHA.108.123752. Epub 2009 Mar 2.
Aging is a major risk factor for hypertension and cardiovascular disease. Accumulating evidence suggests that telomere length is a marker for biological aging of the cardiovascular system. Telomere length is determined by genetic and environmental factors. Studies in different racial populations are required to determine the prognostic value of telomere length in hypertension and cardiovascular diseases. The main objective of this study was to investigate the association between leukocyte telomere length and the risk and prognosis of hypertension in a Chinese population. The relative telomere length of leukocytes was determined by a quantitative PCR-based method in 767 subjects: 379 healthy controls and 388 hypertensive patients, ages 30 to 80 years. The median telomere length ratio, 0.57 (interquartile range: 0.48 to 0.72), was shorter in hypertensive than in healthy normotensive subjects (0.67; interquartile range: 0.53 to 0.93; P<0.001). After 5 years of follow-up, subjects with shorter telomeres were at a higher risk of developing coronary artery disease than individuals with longer telomeres (odds ratio: 3.315; 95% CI: 1.662 to 6.609; P<0.001). Multivariate analysis showed that short telomere length and hypertension were independent risk factors for developing coronary artery disease. Our data suggest that mean leukocyte telomere length is a potential predictor of coronary artery disease and support the hypothesis that differences in biological aging can contribute to the risk and variability of developing hypertension and cardiovascular diseases.
衰老为高血压和心血管疾病的主要风险因素。越来越多的证据表明,端粒长度是心血管系统生物衰老的一个标志物。端粒长度由遗传和环境因素决定。需要在不同种族人群中开展研究,以确定端粒长度在高血压和心血管疾病中的预后价值。本研究的主要目的是调查中国人群中白细胞端粒长度与高血压风险及预后之间的关联。采用基于定量聚合酶链反应的方法,测定了767名年龄在30至80岁之间的受试者的白细胞相对端粒长度,其中包括379名健康对照者和388名高血压患者。高血压患者的端粒长度中位数比值为0.57(四分位间距:0.48至0.72),短于健康血压正常受试者(0.67;四分位间距:0.53至0.93;P<0.001)。经过5年随访,端粒较短的受试者患冠状动脉疾病的风险高于端粒较长者(比值比:3.315;95%置信区间:1.662至6.609;P<0.001)。多变量分析显示,短端粒长度和高血压是发生冠状动脉疾病的独立风险因素。我们的数据表明,白细胞平均端粒长度是冠状动脉疾病的一个潜在预测指标,并支持生物衰老差异可导致高血压和心血管疾病发生风险及变异性的假说。